Treatment Modalities for Basal Like Breast Cancer

Journal Title: Journal of Medical Science And clinical Research - Year 2014, Vol 2, Issue 12

Abstract

Breast cancer represents a heterogeneous group of disorders with significant morbidity and mortality among female population. Basal like breast cancer represents one of the several sub types of breast cancer. It has always been considered synonymous to triple negative breast cancer but studies have repeatedly proven it and triple negative to be two separate entities having different immunohisto chemistry, clinical behavior and prognosis. Basal like breast cancer represents an immunophenotype similar to triple negative breast cancer in a respect that it lacks estrogen receptors (ER), progesterone receptors (PR) and human epithelial growth factor 2 (HER2) overexpression, but is quite distinct at the same time as it represents additional biomarkers as well like cytokeratins 5/6 and epithelial growth factor receptors (EGFR). Moreover, basal like breast cancers is characterized as tumors with greater degree of atypia, higher propensity of local invasion, easy distant metastasis and grim prognosis. Even when it represent as much as 13-37% of breast cancer burden in young female population, definite treatment protocols remain lacking. Thorough analysis of currently available data in this regard has shown that breast conserving therapy (BCT) with adjuvant radiotherapy promises the best outcomes. In addition, preoperative use of chemotherapeutic agents like paclitaxel followed by 5-fluorouracil, doxorubicin, and cyclophosphamide and post-operative use of anthracycline (doxorubicin/cyclophosphamide or fluorouracil/doxorubicin/cyclophosphamide) and CMF based (Cyclophosphamide, Methotrexate, and Fluorouracil) adjuvant chemotherapy has shown to improve the prognosis. Furthermore, therapies that target features like dysfunction of BRCA1 and overexpression of EGFR are currently being studied as potential treatment options.

Authors and Affiliations

Dr. Adnan Bashir MD Bhatti,

Keywords

Related Articles

Insulin Resistance: Alström Syndrome

Alström syndrome is a rare ciliopathy affecting about 1 in 1,000,000 individuals. It is characterized by cone-rod dystrophy, insulin resistance, diabetes mellitus, cardiomyopathy, renal & hepatic dysfunction, hearing los...

Study of pulmonary infection in patients with diabetes Mellitus

Patients with diabetes mellitus are at higher risk of developing pulmonary infections; this study was conducted to study Pulmonary infection in patients with Diabetes mellitus. Material and Method: 50 known cases of Diab...

Clinico-Haematological profile of Anaemia in Diabetic patients: One year study from a region of Jammu and Kashmir

Introduction: Type 2 diabetes has recently escalated in all age groups and is now being seen in younger age groups, including adolescents, especially in high risk populations. Anaemia is one of the common finding in diab...

Roth Spots – A Case Report

Roth spot presents with retinal hemorrhages with white centers. The etiological factors are many, most commonly in infective endocarditis. In this case report we present a severely anemic patient with multiple Roth spots...

Study on Post Menopausal Ladies with Ovarian Mass – Management & Outcome

Background: Ovarian cancer is a common malignancy affecting Indian women and is an important cause of morbidity & mortality especially in elderly women. Main aim was to study the type of ovarian tumour in post menopausal...

Download PDF file
  • EP ID EP208104
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Dr. Adnan Bashir MD Bhatti, (2014). Treatment Modalities for Basal Like Breast Cancer. Journal of Medical Science And clinical Research, 2(12), 3496-3508. https://europub.co.uk/articles/-A-208104